Table 1.
Characteristics | No. of patients | Median OS (year) |
---|---|---|
Age (years) | ||
<60 | 172 (45.6%) | 1.55 |
≥60 | 204 (54.1%) | 1.73 |
NA | 1 (0.3%) | — |
| ||
Gender | ||
Female | 122 (32.4%) | 1.73 |
Male | 255 (67.6%) | 1.58 |
| ||
Histologic grade | ||
G1 | 55 (14.6%) | 1.90 |
G2 | 180 (47.8%) | 1.59 |
G3 | 124 (32.9%) | 1.58 |
G4 | 13 (3.4%) | 1.55 |
NA | 5 (1.3%) | — |
| ||
Pathological stage | ||
I | 175 (46.4%) | 1.75 |
II | 87 (23.1%) | 1.56 |
III | 86 (22.8%) | 1.14 |
IV | 5 (1.3%) | 0.61 |
NA | 24 (6.4%) | — |
| ||
T | ||
T1 | 185 (49.1%) | 1.75 |
T2 | 95 (25.2%) | 1.65 |
T3 | 81 (21.5%) | 1.12 |
T4 | 13 (3.4%) | 1.39 |
NA | 3 (0.8%) | — |
| ||
N | ||
N0 | 257 (68.2%) | 1.63 |
N1-2 | 4 (1.1%) | 1.79 |
NA | 116 (30.7%) | — |
| ||
M | ||
M0 | 272 (72.1%) | 1.62 |
M1 | 4 (1.1%) | 1.07 |
NA | 101 (26.8%) | — |
T: tumor; N: node; M: metastasis; OS: overall survival; NA: not available.